Table 4

Causes of death (13 patients) for patients receiving rituximab for ITP

Sex (F, M)/age (y)Cause of deathDelay after first rituximab infusion (mo)Death related to rituximab
F, 18 Cerebral hemorrhage, refractory ITP No 
M, 67 Massive bleeding with shock, refractory ITP 12 No 
F, 43 Sudden death at home 26 No 
M, 86 “Old age” 16 No 
M, 97 “Old age” No 
M, 81 Cachexia 16 No 
M, 80 Suicide No 
M, 76 Multiple myeloma 13 No 
M, 80 ND Possible 
M, 80 ND 39 No 
M, 70 Infection, Enterococcus faecium 12 Possible 
M, 73 Infection, Staphylococcus aureus 13 Possible 
F, 74 Infection, Enterobacter cloacae 14 Possible 
Sex (F, M)/age (y)Cause of deathDelay after first rituximab infusion (mo)Death related to rituximab
F, 18 Cerebral hemorrhage, refractory ITP No 
M, 67 Massive bleeding with shock, refractory ITP 12 No 
F, 43 Sudden death at home 26 No 
M, 86 “Old age” 16 No 
M, 97 “Old age” No 
M, 81 Cachexia 16 No 
M, 80 Suicide No 
M, 76 Multiple myeloma 13 No 
M, 80 ND Possible 
M, 80 ND 39 No 
M, 70 Infection, Enterococcus faecium 12 Possible 
M, 73 Infection, Staphylococcus aureus 13 Possible 
F, 74 Infection, Enterobacter cloacae 14 Possible 
Close Modal

or Create an Account

Close Modal
Close Modal